Effect of proton pomp inhibitor (PPI : Rabeprazole) on reflux esophagitis after endoscopic injection sclerotherapy (EIS), a randomized control study (24 hour-pH monitoring).

@article{Akahoshi2013EffectOP,
  title={Effect of proton pomp inhibitor (PPI : Rabeprazole) on reflux esophagitis after endoscopic injection sclerotherapy (EIS), a randomized control study (24 hour-pH monitoring).},
  author={Tomohiko Akahoshi and Hirofumi Kawanaka and Morimasa Tomikawa and Hiroshi Saeki and Hideaki Uchiyama and Tetsuo Ikeda and Ken Shirabe and Makoto Hashizume and Yoshihiko Maehara},
  journal={Fukuoka igaku zasshi = Hukuoka acta medica},
  year={2013},
  volume={104 12},
  pages={483-9}
}
BACKGROUND Transient esophageal ulceration is a common finding after sclerotherapy of varices. These ulcers sometimes cause pain, ulcer bleeding, and stricture formation. Gastroesophageal reflux (GER) after Endoscopic injection sclerotherapy (EIS) is a known cause of worsening ulcer formation. Therefore, an efficient drug for GER is desirable to improve the quality of life of patients with esophageal varices. METHODS We randomized 18 Japanese cirrhotic patients who had risky esophageal… CONTINUE READING